ILB-3000

N/A

Report date: 2024/10/15 17:46:07

First In Class

Base Information

Drug NameILB-3000

Drug Alias NameILB-3000

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsFibrosisAutoimmune Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesInnolake Biopharm (Hangzhou) Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesInnolake Biopharm (Hangzhou) Co Ltd

Inactive CompaniesN/A

Active IndicationsFibrosisAutoimmune Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A